Immuneering Corp. (IMRX)

5.02 +0.16 (+3.29%) USD  |  NASDAQ  |  Mar 20, 16:00
5.05 +0.03 (+0.60%) After-Hours: 20:00
More

Immuneering EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for IMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Verastem, Inc. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
X4 Pharmaceuticals, Inc. Upgrade